Negative v positive schizophrenia. Definition and validation
- PMID: 7165478
- DOI: 10.1001/archpsyc.1982.04290070025006
Negative v positive schizophrenia. Definition and validation
Abstract
We developed criteria for dividing the schizophrenic syndrome into three subtypes: positive, negative, and mixed schizophrenia. Positive schizophrenia is characterized by prominent delusions, hallucinations, positive formal thought disorder, and persistently bizarre behavior; negative schizophrenia, by affective flattening, alogia, avolition, anhedonia, and attentional impairment. In mixed schizophrenia either both negative and positive symptoms are prominent, or neither is prominent. We explored the validity of these criteria in a variety of ways. Significant differences between the three types were noted using external validators such as premorbid adjustment, indices of cognitive dysfunction, ventricular brain ratio, and course in hospital. The correlational structure of the symptom complexes also provided further support for our approach to subtyping.
Similar articles
-
Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms.Am J Psychiatry. 1982 Mar;139(3):297-302. doi: 10.1176/ajp.139.3.297. Am J Psychiatry. 1982. PMID: 7058942
-
Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms.Schizophr Res. 1991 Mar-Apr;4(2):71-9. doi: 10.1016/0920-9964(91)90026-n. Schizophr Res. 1991. PMID: 2039764
-
Positive and negative subtypes of schizophrenia. A study from India.Acta Psychiatr Scand. 1986 Oct;74(4):353-9. doi: 10.1111/j.1600-0447.1986.tb06254.x. Acta Psychiatr Scand. 1986. PMID: 3811996
-
Schizophrenia: refining the phenotype, resolving endophenotypes.Behav Res Ther. 1999 Mar;37(3):281-95. doi: 10.1016/s0005-7967(98)00138-7. Behav Res Ther. 1999. PMID: 10087646 Review.
-
Meta-analysis of the factor structure of the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS).Schizophr Res. 2024 Dec;274:464-472. doi: 10.1016/j.schres.2024.10.027. Epub 2024 Nov 7. Schizophr Res. 2024. PMID: 39515256 Review.
Cited by
-
Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study.Ind Psychiatry J. 2014 Jan;23(1):27-35. doi: 10.4103/0972-6748.144953. Ind Psychiatry J. 2014. PMID: 25535442 Free PMC article.
-
Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.Curr Mol Med. 2015;15(2):176-83. doi: 10.2174/1566524015666150303104811. Curr Mol Med. 2015. PMID: 25732147 Free PMC article.
-
Do Microplastics Have Neurological Implications in Relation to Schizophrenia Zebrafish Models? A Brain Immunohistochemistry, Neurotoxicity Assessment, and Oxidative Stress Analysis.Int J Mol Sci. 2024 Jul 30;25(15):8331. doi: 10.3390/ijms25158331. Int J Mol Sci. 2024. PMID: 39125900 Free PMC article.
-
Subtyping first-episode non-affective psychosis using four early-course features: potentially useful prognostic information at initial presentation.Early Interv Psychiatry. 2014 Feb;8(1):50-8. doi: 10.1111/eip.12026. Epub 2013 Jan 24. Early Interv Psychiatry. 2014. PMID: 23343467 Free PMC article.
-
Weakened center-surround interactions in visual motion processing in schizophrenia.J Neurosci. 2006 Nov 1;26(44):11403-12. doi: 10.1523/JNEUROSCI.2592-06.2006. J Neurosci. 2006. PMID: 17079669 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical